Impact of calcineurin inhibitors with or without interferon on hepatitis C virus titers in a chimeric mouse model of hepatitis C virus infection (Q43039673)

From Wikidata

Jump to navigation Jump to search

scientific article published in January 2012

Language	Label	Description	Also known as
English	Impact of calcineurin inhibitors with or without interferon on hepatitis C virus titers in a chimeric mouse model of hepatitis C virus infection	scientific article published in January 2012

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Impact of calcineurin inhibitors with or without interferon on hepatitis C virus titers in a chimeric mouse model of hepatitis C virus infection (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Hepatitis C virus

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Norman M Kneteman

1

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Sonal Asthana

2

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Jamie Lewis

3

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Chelcey Dibben

4

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Donna Douglas

5

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Mahra Nourbakhsh

6

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Lorne J Tyrrell

7

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Garry Lund

8

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

publication date

1 January 2012

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Liver Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

18

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

38-44

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Reinfection of liver graft by hepatitis C virus after liver transplantation

1 reference

https://api.crossref.org/works/10.1002%2FLT.22400

21 January 2018

A longitudinal analysis of hepatitis C virus replication following liver transplantation

1 reference

https://api.crossref.org/works/10.1002%2FLT.22400

21 January 2018

HCV-related fibrosis progression following liver transplantation: increase in recent years

1 reference

https://api.crossref.org/works/10.1002%2FLT.22400

21 January 2018

Cyclosporin A suppresses replication of hepatitis C virus genome in cultured hepatocytes

1 reference

https://api.crossref.org/works/10.1002%2FLT.22400

21 January 2018

Significant improvement in the outcome of HCV-infected transplant recipients by avoiding rapid steroid tapering and potent induction immunosuppression.

1 reference

https://api.crossref.org/works/10.1002%2FLT.22400

21 January 2018

Impact of tacrolimus versus cyclosporine in hepatitis C virus-infected liver transplant recipients on recurrent hepatitis: a prospective, randomized trial

1 reference

https://api.crossref.org/works/10.1002%2FLT.22400

21 January 2018

Immunosuppression with calcineurin inhibitors with respect to the outcome of HCV recurrence after liver transplantation: results of a meta-analysis.

1 reference

https://api.crossref.org/works/10.1002%2FLT.22400

21 January 2018

Cyclosporine suppresses hepatitis C virus in vitro and increases the chance of a sustained virological response after liver transplantation.

1 reference

https://api.crossref.org/works/10.1002%2FLT.22400

21 January 2018

Hepatitis C virus replication in mice with chimeric human livers

1 reference

https://api.crossref.org/works/10.1002%2FLT.22400

21 January 2018

Anti-HCV therapies in chimeric scid-Alb/uPA mice parallel outcomes in human clinical application

1 reference

https://api.crossref.org/works/10.1002%2FLT.22400

21 January 2018

HCV796: A selective nonstructural protein 5B polymerase inhibitor with potent anti-hepatitis C virus activity in vitro, in mice with chimeric human livers, and in humans infected with hepatitis C virus

1 reference

https://api.crossref.org/works/10.1002%2FLT.22400

21 January 2018

Suppression of hepatitis C virus replication by cyclosporin a is mediated by blockade of cyclophilins

1 reference

https://api.crossref.org/works/10.1002%2FLT.22400

21 January 2018

Evaluation of a cyclophilin inhibitor in hepatitis C virus-infected chimeric mice in vivo

1 reference

https://api.crossref.org/works/10.1002%2FLT.22400

21 January 2018

Effect of calcineurin inhibitors in the outcome of liver transplantation in hepatitis C virus-positive recipients.

1 reference

https://api.crossref.org/works/10.1002%2FLT.22400

21 January 2018

The use of cyclosporine for recurrent hepatitis C after liver transplant: a randomized pilot study

1 reference

https://api.crossref.org/works/10.1002%2FLT.22400

21 January 2018

Reassessing selection criteria prior to liver transplantation for hepatocellular carcinoma utilizing the Scientific Registry of Transplant Recipients database

1 reference

https://api.crossref.org/works/10.1002%2FLT.22400

21 January 2018

SCY-635, a Novel Nonimmunosuppressive Analog of Cyclosporine That Exhibits Potent Inhibition of Hepatitis C Virus RNA Replication In Vitro

1 reference

https://api.crossref.org/works/10.1002%2FLT.22400

21 January 2018

The cyclophilin inhibitor Debio 025 combined with PEG IFNalpha2a significantly reduces viral load in treatment-naïve hepatitis C patients.

1 reference

https://api.crossref.org/works/10.1002%2FLT.22400

21 January 2018

Cyclosporine Inhibits a Direct Interaction between Cyclophilins and Hepatitis C NS5A

1 reference

https://api.crossref.org/works/10.1002%2FLT.22400

21 January 2018

A major determinant of cyclophilin dependence and cyclosporine susceptibility of hepatitis C virus identified by a genetic approach

1 reference

https://api.crossref.org/works/10.1002%2FLT.22400

21 January 2018

HCV resistance to cyclosporin A does not correlate with a resistance of the NS5A-cyclophilin A interaction to cyclophilin inhibitors

1 reference

https://api.crossref.org/works/10.1002%2FLT.22400

21 January 2018

DEB025 (Alisporivir) inhibits hepatitis C virus replication by preventing a cyclophilin A induced cis-trans isomerisation in domain II of NS5A

1 reference

https://api.crossref.org/works/10.1002%2FLT.22400

21 January 2018

Identifiers

10.1002/LT.22400

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43039673&oldid=1978310676"